The Be-Home Kids Program: An Integrated Approach for Delivering Behavioral Therapies to Adolescents with Episodic and Chronic Migraine.
Licia GrazziDanilo Antonio MontisanoAlberto RaggiPaul B RizzoliPublished in: Brain sciences (2023)
Migraine disorders are common in populations of children and adolescents. There are different pharmacological treatments for migraine in young patients, but none have specific indications, and doubts about their efficacy exist. The feasibility and effectiveness of behavioral approaches have already been documented in clinical experiences, and they are generally associated with fewer or no unpleasant effects. Among them, mindfulness practice offers a suitable alternative to other adolescent treatments. We present the results of a pilot study, the Be-Home Kids program, performed during the COVID-19 emergency. It was delivered by web and included education on drug use, lifestyle issues, and six sessions of mindfulness-based behavioral practice. We assessed headache frequency, medication intake, and other psychological variables and followed twenty-one adolescents with chronic or high-frequency episodic migraine without aura for 12 months. Results indicated an overall clinical improvement, particularly a 64% reduction in headache frequency over 12 months. In conclusion, our results indicate that a combined treatment which includes patients' education and six sessions of mindfulness-based practice delivered over the web, can be of great support in reducing headache frequency, medication intake, and the associated psychological burden disability in adolescent migraine patients.
Keyphrases
- healthcare
- end stage renal disease
- young adults
- high frequency
- newly diagnosed
- ejection fraction
- quality improvement
- chronic kidney disease
- primary care
- mental health
- physical activity
- metabolic syndrome
- randomized controlled trial
- chronic pain
- emergency department
- public health
- peritoneal dialysis
- systematic review
- type diabetes
- body mass index
- patient reported
- adverse drug